Only products of the highest quality have been given FDA approval, maybe A2 should ask its more succesful competitors how it can improve its offerings so it doesn't get overlooked in the future.
Maybe they can start with Care A2+, seeing how they too, deliver products with the A2 strain.
Nothing but the best for US infants when it comes to infant formula it would seem. Don't shoot the messenger, i'm not the US FDA that makes these decisions and you'd think, they know what they're doing.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.92 |
Change
0.040(0.51%) |
Mkt cap ! $5.734B | |||
| Open | High | Low | Value | Volume |
| $7.86 | $7.96 | $7.83 | $29.31M | 3.709M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $7.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.94 | 120 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |